WeightWatchers introduced its partnership with Personify Well being to permit employers to supply the corporate’s enterprise options to assist workers entry weight-related healthcare choices, together with behavioral well being, remedy administration and digital care.
WeightWatchers for Enterprise provides packages targeted on altering habits, together with packages tailor-made for people with diabetes or these on GLP-1 medicines. The corporate additionally provides digital medical care and drugs administration, neighborhood boards, teaching help, and well being information and analytics.
Personify Well being, which is the results of a $3 billion merger between Virgin Pulse’s employee-wellness and engagement firm and HealthComp’s well being plan-administration group, provides one platform with well being, navigation, advantages and wellbeing experiences, alongside data-driven personalization.
Firms utilizing Personify Well being may have the choice to supply their workers WeightWatchers for Enterprise to entry the burden well being firm’s B2B choices.
“We’re grateful for our partnership with Personify Well being and proud to work alongside them as some of the progressive leaders within the trade,” Rémi Cossart, head of WeightWatchers Clinic and WeightWatchers for Enterprise, stated in a press release.
“We perceive the significance of weight well being care and the wants of organizations, and are excited to open up entry to Personify Well being’s community to assist remove weight bias, maximize personalised well being outcomes, and guarantee high quality care.”
THE LARGER TREND
Virgin Pulse and HealthComp rebranded as Personify Well being in February combining the businesses choices.
The variety of digital well being corporations providing platforms targeted on GLP-1 medicines has elevated this yr.
Final month, meals and diet app MyFitnessPal launched new choices and content material to assist members taking GLP-1s maximize their nutrient consumption whereas getting access to recipes, neighborhood boards and drugs monitoring.
In January, digital weight reduction firm Noom introduced its business enterprise, Noom for Work, would accomplice with Liviniti, a nationwide pharmacy profit supervisor. Collectively, the pair would provide plan sponsors and their workers a digital GLP-1 Companion for persistent weight situations.
Traders additionally see the promise of GLP-1s in making an influence on affected person weight reduction, together with Andreesseen Horowitz funding accomplice Jay Rughani whom spoke to Our blogNews on the topic in December and managing director at Normal Catalyst Holly Maloney who joined the publication to debate the rise in adoption of GLP-1s in January.
